Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free

Rocket Lab Announces Third Quarter 2026 Financial Results: Posts Record Revenue, $1.2 Billion or 52% Sequential Quarterly Backlog Growth, Positive GAAP Operating Cash Flow, and Guides to Record Revenue and Gross Margin Expansion in Q4 2026

By Rocket Lab Corporation | November 09, 2026, 4:05 PM

RKLB Q3 2026 highlights

RKLB Q3 2026 highlights
RKLB Q3 2026 highlights

LONG BEACH, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space systems, today shared the financial results for fiscal third quarter ended September 30, 2026.

Rocket Lab founder and CEO, Sir Peter Beck, says: “Q3 2026 was a defining quarter for Rocket Lab. We delivered a record $268 million in revenue ($34 million higher than Q2 2026) alongside a record backlog which has grown to $3.57 billion. Nearly $1 billion of that backlog comes from new launch contracts, signed in Q3 2026 alone, as well as $470 million signed for Space Systems. Our end-to-end space strategy is delivering exactly as designed: the world's most critical and ambitious missions increasingly rely on Rocket Lab for launch, spacecraft, and components, sometimes all on a single mission, and every part of our business is growing as a result.”

Highlights for the Third Quarter 2026, plus business updates since September 30, 2026.

  • Record quarterly revenue of $268 million, a 73% increase year-on-year.
  • Record backlog of approximately $3.6 billion, a 52% increase since end of Q2 2026.
  • Positive GAAP operating cash flow of $7.2M.
  • Approximately $1 billion in new launch contracts signed across Electron, HASTE, and Neutron, bringing Rocket Lab’s total launch backlog to 117 launches: a new record.
  • Secured over $515M in Neutron launch contracts from constellation operators in Q3, growing the rocket’s backlog to 16 missions ahead of its debut and lifting the base launch price to $70 million for several of these missions as industry launch capacity tightens. With first launch now targeted for no earlier than 2027, critical milestones continue to be achieved across assembly, integration, testing, and delivery of first flight hardware to Launch Complex 3.
  • Twelve Rocket Lab-built spacecraft successfully launched to orbit and now operating, including eight satellite platforms for Globalstar’s direct-to-device communications constellation, twin spacecraft conducting Mars science for NASA, the responsive space VICTUS HAZE mission for the United States Space Force, and a single spacecraft for Viasat’s NASA Communications Services Depot.
  • More than 55 spacecraft now in development and build across Rocket Lab’s production complexes, including spacecraft for NASA, the Space Development Agency, USSF, and commercial constellation operators.
  • Fully funded Rocket Lab’s pending acquisition of Iridium Communications through a completed ATM equity offering and received approval by Iridium lenders to maintain Iridium’s credit facility post-transaction, and obtained overwhelming approval from Iridium shareholders in favor of the acquisition.

Fourth Quarter 2026 Guidance
For the fourth quarter of 2026, Rocket Lab expects:

  • Revenue between $270 million and $290 million.
  • GAAP Gross Margins between 34% and 36%.
  • Non-GAAP Gross Margins between 39% and 41%.
  • GAAP Operating Expenses between $162 million and $168 million.
  • Non-GAAP Operating Expenses between $136 million and $142 million.
  • Interest Income net $45 million.
  • Adjusted EBITDA loss of between $14 million and $20 million.
  • Basic Weighted Average Common Shares Outstanding of 681 million, including approximately 41 million of Series A Convertible Participating Preferred Shares.

See “Use of Non-GAAP Financial Measures” below for an explanation of our use of Non-GAAP financial measures, and the reconciliation of historical Non-GAAP measures to the comparable GAAP measures in the tables attached to this press release. We have not provided a reconciliation for the forward-looking Non-GAAP Gross Margin, Non-GAAP Operating Expenses or Adjusted EBITDA expectations for Q4 2026 described above because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. Stock-based compensation is currently expected to range from $17 million to $19 million in Q4 2026.

Conference Call Information
Rocket Lab will host a conference call for investors at 2 p.m. PT (5 p.m. ET) today to discuss these business highlights and financial results for our third quarter, other updates, and to provide our outlook for the fourth quarter 2026.

The live webcast and a replay of the webcast will be available on Rocket Lab’s Investor Relations website: https://investors.rocketlabcorp.com/

Rocket Lab Investor Relations Contact
Patrick Vorenkamp
investors@rocketlabusa.com

Rocket Lab Media Contact
Murielle Baker
media@rocketlabusa.com

About Rocket Lab
Rocket Lab (Nasdaq: RKLB) is an end-to-end space company delivering rockets, satellites, and spacecraft components for commercial, government, and defense missions. Driven by its industry-leading small-lift rockets Electron and HASTE and its upcoming reusable Neutron medium-lift rocket, Rocket Lab delivers reliable and responsive launch for the world’s most important missions from constellation deployment to missile defense. Rocket Lab’s satellites and components have powered more than 1,700 missions in Earth orbit, as well as deep-space exploration of the Moon, Mars, and beyond. Learn more at www.rocketlabcorp.com.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our expectations of financial results for the fourth quarter of 2026, launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development and anticipated timeline to launch, operational expansion, business strategy, our backlog, revenue momentum, and contract activity; and the anticipated benefits or impacts of our pending acquisition of Iridium Communications are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.investors.rocketlabcorp.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

Use of Non-GAAP Financial Measures
We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America (“GAAP”) with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company's ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly filed reports in their entirety and not to rely on any single financial measure. Reconciliation of the non-GAAP financial information to the corresponding GAAP measures for the historical periods disclosed are included at the end of the tables in this press release. We have not provided a reconciliation for forward-looking non-GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. The following definitions are provided:

Adjusted EBITDA
EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.

Other Non-GAAP Financial Measures

Non-GAAP gross profit, gross margin, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.

    
ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
(unaudited; in thousands, except share and per share data)

    
 Three Months Ended September 30, Nine Months Ended September 30,
 2026
 2025
 2026
 2025
Revenues:       
Product revenues$197,487  $104,042  $506,322  $277,571 
Service revenues 70,347   51,038   195,926   144,576 
Total revenues 267,834   155,080   702,248   422,147 
Cost of revenues:       
Cost of product revenues 133,077   72,841   331,600   188,402 
Cost of service revenues 44,686   24,925   119,508   94,796 
Total cost of revenues 177,763   97,766   451,108   283,198 
Gross profit 90,071   57,314   251,140   138,949 
Operating expenses:       
Research and development, net 98,388   70,694   261,330   191,937 
Selling, general and administrative 70,872   45,589   182,482   124,808 
Total operating expenses 169,260   116,283   443,812   316,745 
Operating loss (79,189)  (58,969)  (192,672)  (177,796)
Other income (expense):       
Interest expense (323)  (7,285)  (2,178)  (21,470)
Interest income 28,627   6,695   55,262   15,923 
Gain (loss) on foreign exchange 473   388   (1,325)  (235)
Loss on extinguishment of debt (27,259)  —   (27,259)  — 
Other income (expense), net 1,497   (177)  1,253   (675)
Total other income (expense), net 3,015   (379)  25,753   (6,457)
Loss before income taxes (76,174)  (59,348)  (166,919)  (184,253)
(Provision) benefit for income taxes (3,503)  41,091   (7,038)  38,966 
Net loss$(79,677) $(18,257) $(173,957) $(145,287)
Net loss per share attributable to Rocket Lab Corporation:       
Basic and diluted$(0.12) $(0.03) $(0.28) $(0.28)
Weighted-average common shares outstanding:       
Basic and diluted 652,263,684   528,725,980   629,298,251   516,560,266 
                


ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF SEPTEMBER 30, 2026 AND DECEMBER 31, 2025
(unaudited; in thousands, except share and per share values)

    
 September 30, 2026 December 31, 2025
Assets   
Current assets:   
Cash and cash equivalents$4,447,665  $828,660 
Marketable securities, current 160,290   187,917 
Accounts receivable, net 118,311   39,001 
Contract assets 124,361   61,606 
Inventories 280,885   158,407 
Prepaids and other current assets 121,413   89,953 
Total current assets 5,252,925   1,365,544 
Non-current assets:   
Property, plant and equipment, net 410,083   319,473 
Intangible assets, net 307,849   224,746 
Goodwill 301,420   205,750 
Right-of-use assets - operating leases 112,449   90,371 
Right-of-use assets - finance leases 12,155   13,895 
Marketable securities, non-current 95,894   82,247 
Restricted cash 8,414   4,885 
Deferred income tax assets, net 2,009   1,895 
Other non-current assets 65,509   15,672 
Total assets$6,568,707  $2,324,478 
Liabilities and Stockholders’ Equity   
Current liabilities:   
Trade payables$85,150  $72,699 
Accrued expenses 19,285   19,299 
Employee benefits payable 45,068   25,803 
Contract liabilities 423,580   195,438 
Other current liabilities 41,035   21,237 
Total current liabilities 614,118   334,476 
Non-current liabilities:   
Convertible senior notes, net 1,289   152,395 
Long-term borrowings, net 1,716   1,716 
Non-current operating lease liabilities 102,905   85,191 
Non-current finance lease liabilities 14,374   14,653 
Deferred income tax liabilities 10,399   1,241 
Other non-current liabilities 21,336   12,952 
Total liabilities 766,137   602,624 
COMMITMENTS AND CONTINGENCIES   
Stockholders’ equity:   
Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: 40,951,250 and 45,951,250 at September 30, 2026 and December 31, 2025, respectively 4   5 
Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 680,114,963 and 589,525,802 at September 30, 2026 and December 31, 2025, respectively; outstanding shares: 639,163,713 and 543,574,552 at September 30, 2026 and December 31, 2025, respectively 64   54 
Treasury stock, at cost; shares: 40,951,250 and 45,951,250 at September 30, 2026 and December 31, 2025, respectively —   — 
Additional paid-in capital 6,998,701   2,735,669 
Accumulated deficit (1,185,867)  (1,011,910)
Accumulated other comprehensive loss (10,332)  (1,964)
Total stockholders’ equity 5,802,570   1,721,854 
Total liabilities and stockholders’ equity$6,568,707  $2,324,478 
        


ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
(unaudited; in thousands)
  
 For the Nine Months Ended
September 30,
 2026
 2025
CASH FLOWS FROM OPERATING ACTIVITIES:   
Net loss$(173,957) $(145,287)
Adjustments to reconcile net loss to net cash used in operating activities:   
Depreciation and amortization 57,651   29,191 
Stock-based compensation expense 66,001   52,894 
(Gain) loss on disposal of assets (369)  2,356 
Loss on equity securities 882   — 
Loss on extinguishment of debt 27,259   — 
Lower of cost or market inventory valuation adjustments 7,462   — 
Amortization of inventory step-up 399   — 
Amortization of debt issuance costs and discount 189   2,551 
Noncash lease expense 9,863   5,975 
Change in the fair value of contingent consideration (2,058)  — 
Accretion of marketable securities purchased at a discount (1,278)  (1,599)
Deferred income taxes 514   (33,049)
Changes in operating assets and liabilities:   
Accounts receivable, net (68,468)  (19,442)
Contract assets (60,769)  12,608 
Inventories (83,731)  (25,567)
Prepaids and other current assets (20,501)  (17,455)
Other non-current assets (48,622)  10,132 
Trade payables 6,892   (1,634)
Accrued expenses (280)  2,671 
Employee benefits payable 11,875   43,417 
Contract liabilities 144,485   (9,187)
Other current liabilities 9,859   (1,358)
Non-current lease liabilities (10,775)  (8,269)
Other non-current liabilities 223   62 
Net cash used in operating activities (127,254)  (100,990)
CASH FLOWS FROM INVESTING ACTIVITIES:   
Purchases of property, equipment and software (84,185)  (106,631)
Proceeds on disposal of assets 715   397 
Cash paid for business combinations, net of acquired cash (44,271)  (132,441)
Purchases of marketable securities (221,667)  (187,780)
Maturities of marketable securities 235,515   179,822 
Sale of marketable securities —   3,383 
Net cash used in investing activities (113,893)  (243,250)
CASH FLOWS FROM FINANCING ACTIVITIES:   
Proceeds from ATM Equity Offerings 3,911,859   865,453 
Issuance costs related to ATM Equity Offerings (36,695)  (20,134)
Proceeds from the exercise of stock options 1,778   2,539 
Proceeds from Employee Stock Purchase Plan 13,605   7,751 
Proceeds from sale of employees’ restricted stock units to cover taxes 190,665   80,659 
Minimum tax withholding paid on behalf of employees for restricted stock units (189,835)  (65,672)
Proceeds from secured term loans —   26,716 
Repayments on secured term loan —   (15,103)
Payment of debt issuance and extinguishment costs (27,259)  (278)
Finance lease principal payments (232)  (197)
Net cash provided by financing activities 3,863,886   881,734 
Effect of exchange rate changes on cash and cash equivalents (205)  (86)
Net increase in cash and cash equivalents and restricted cash 3,622,534   537,408 
Cash and cash equivalents, and restricted cash, beginning of period 833,545   275,302 
Cash and cash equivalents, and restricted cash, end of period$4,456,079  $812,710 
        

ROCKET LAB CORPORATION AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
(unaudited; in thousands)

The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures.

 Three Months Ended September 30, Nine Months Ended September 30,
2026
 2025
 2026
 2025
NET LOSS$(79,677) $(18,257) $(173,957) $(145,287)
Depreciation 9,550   6,490   27,236   18,061 
Amortization 12,168   5,236   30,415   11,130 
Stock-based compensation expense 18,324   15,727   66,001   52,894 
Transaction costs 21,340   5,118   31,584   11,504 
Interest expense 323   7,285   2,178   21,470 
Interest income (28,627)  (6,695)  (55,262)  (15,923)
Change in fair value of contingent consideration (2,444)  —   (2,058)  — 
Amortization of inventory step-up 216   —   399   — 
Provision (benefit) for income taxes 3,503   (41,091)  7,038   (38,966)
(Gain) loss on foreign exchange (473)  (388)  1,325   235 
Loss on equity securities 882   —   882   — 
Accretion of marketable securities and cash equivalents purchased at a discount (425)  (553)  (1,302)  (1,810)
Loss (gain) on disposal of assets 34   853   (369)  2,356 
Employee retention credit —   —   —   515 
Loss on extinguishment of debt 27,259   —   27,259   — 
ADJUSTED EBITDA$(18,047) $(26,275) $(38,631) $(83,821)
                


 Three Months Ended September 30, Nine Months Ended September 30,
2026
 2025
 2026
 2025
GAAP Gross profit$90,071  $57,314  $251,140  $138,949 
Stock-based compensation 4,773   3,539   13,369   12,351 
Amortization of purchased intangibles and favorable lease 7,692   4,126   20,970   7,772 
Amortization of inventory step-up 216   —   399   — 
Employee retention credit —   —   —   278 
Non-GAAP Gross profit$102,752  $64,979  $285,878  $159,350 
Non-GAAP Gross margin 38.4%  41.9%  40.7%  37.7%
        
GAAP Research and development, net$98,388  $70,694  $261,330  $191,937 
Stock-based compensation (5,645)  (5,588)  (18,425)  (16,055)
Amortization of purchased intangibles and favorable lease —   —   —   (329)
Employee retention credit —   —   —   (88)
Non-GAAP Research and development, net$92,743  $65,106  $242,905  $175,465 
        
GAAP Selling, general and administrative$70,872  $45,589  $182,482  $124,808 
Stock-based compensation (7,906)  (6,600)  (34,207)  (24,488)
Amortization of purchased intangibles and favorable lease (4,192)  (846)  (8,599)  (2,250)
Transaction costs (21,340)  (5,118)  (31,584)  (11,504)
Employee retention credit —   —   —   (149)
Non-GAAP Selling, general and administrative$37,434  $33,025  $108,092  $86,417 
        
GAAP Operating expenses$169,260  $116,283  $443,812  $316,745 
Stock-based compensation (13,551)  (12,188)  (52,632)  (40,543)
Amortization of purchased intangibles and favorable lease (4,192)  (846)  (8,599)  (2,579)
Transaction costs (21,340)  (5,118)  (31,584)  (11,504)
Employee retention credit —   —   —   (237)
Non-GAAP Operating expenses$130,177  $98,131  $350,997  $261,882 
        
GAAP Operating loss$(79,189) $(58,969) $(192,672) $(177,796)
Total non-GAAP adjustments 51,764   25,817   127,553   75,264 
Non-GAAP Operating loss$(27,425) $(33,152) $(65,119) $(102,532)
        
GAAP Total other income (expense), net$3,015  $(379) $25,753  $(6,457)
(Gain) loss on foreign exchange (473)  (388)  1,325   235 
Loss on equity securities 882   —   882   — 
Loss (gain) on disposal of assets 34   853   (369)  2,356 
Loss on extinguishment of debt 27,259   —   27,259   — 
Change in fair value of contingent consideration (2,444)  —   (2,058)  — 
Non-GAAP Total other income (expense), net$28,273  $86  $52,792  $(3,866)
                

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/854ada2d-ce93-4a65-9f61-1900c14910d4


Mentioned In This Article

Latest News

57 min
1 hour
2 hours
2 hours
2 hours
2 hours
14 hours
15 hours
18 hours
Nov-08
Nov-07
Nov-06
Nov-05
Nov-04
Nov-03